which-can-lead-numbness
Instruct the patient in the aplastic anemia and its causes. Encouraged the importance to avoiding contact to persons known to have serious infections, trauma, abrasions, and breakdown of the skin which could lead to infection. Encouraged that antibiotics must be taken for the entire period prescribed. Encouraged the need to maintain a well-balanced diet.
Patient instructed on the importance of alternating insulin injection sites, reviewed alternative injection sites. Instructed injecting into the same spot can cause lipohypertrophy, the buildup of fat under the skin, which can slow the absorption of insulin, or lipoatrophy, the wasting of fat under the skin, which can be unsightly.
Patient was instructed on proper skin care after bathing. Do not put oils or creams between the toes. The extra moisture can lead to infection. Also don't soak the feet that can dry the skin.
Patient was instructed on eyes complications. Diabetes can cause eye problems and may lead to blindness. People with diabetes do have a higher of blindness than people without diabetes. Early detection and treatment of eye problems can save the sight.
SN instructed patient/PCG on aspiration as the most common complication related to tube feeding. SN explained that this occurs when food is actually inhaled into the lungs (can lead to pneumonia), but if patient is kept upright during feeding, this complication can be greatly minimized.
Instructed patient watch for these problems: a hole in the skin where the IV is -- medicine or fluid can go into the tissue around the vein. This could harm the skin or tissue.Swelling of the vein -- this can lead to a blood clot (called thrombophlebitis).
SN instructed patient and caregiver that Apixaban ( Eliquis ) is a anticoagulant for the treatment of venous thromboembolic events. It is indicated for the following: to lower the risk of stroke and embolism in patients with nonvalvular atrial fibrillation, deep vein thrombosis ( DVT ) prophylaxis. DVT's may lead to pulmonary embolism ( PE ) in knee or hip replacement surgery patients, treatment of both DVT and PE, to reduce the risk of recurrent DVT and PE after initial therapy. Apixaban can increase the risk of bleeding and may cause serious, potentially fatal, bleeding. Concurrent use with drugs affecting hemostasis ( e.g. other anticoagulants, heparin, aspirin and other antiplatelet drugs, selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and non steroidal anti-inflammatory drugs ( NSAIDs ) can further increase the risk of bleeding.
SN instructed patient that fluid restrictions are usually necessary when dialysis is initiated, especially if dialysis only occurs three days a week and if urine production is decreased. Build up of fluid can lead to shortness of breath, swelling, and high blood pressure. There is a limit to the amount of fluid that can be safely removed during dialysis. If fluid limits are exceeded and extra water must be removed, negative effects such as muscle cramping, low blood pressure leading to nausea, weakness, dizziness, and possibly extra dialysis sessions to remove the fluid.
Patient was instructed about to tell the doctor about any changes in sensation in the toes, feet, or legs. Speak up if note pain, tingling, a pins-and-needles feeling, numbness, or any other unusual signs - even if it seems trivial to the patient. Further teaching is needed.
Patient was instructed on the importance of a good foot care. Check the feet every day, redness, pain that won't go away, numbness, or tingling.